About Myles Greenberg
Form D filings for Alucent Biomedical from 2020 to 2023 list Myles Greenberg as president and director.
Form D filings also name Myles Greenberg as a director at Vertos Medical.
Myles Greenberg first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Myles Greenberg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Myles Greenberg works with at each company, as listed on that company's latest Form D.
Alucent Biomedical, Inc. · Form D, Apr 20, 2023
JL
Julie Lautt
Director
JC
James Corbett
Director
BK
Bruce Krattenmaker
Executive officer
KW
Kevin Warner
Executive officer
CJ
Colin Jackson
Executive officer
DF
David Flicek
Director
KK
Katalin Kauser
Executive officer
DP
Daniel Pelak
Director
NP
Nick Pappas
Director
JI
James Isaacson
Executive officer
HH
Henry Hauser
Executive officer
Vertos Medical Inc. · Form D, May 12, 2015
JR
John Ryan
Director
BF
Bruce Feuchter
Secretary
EW
Eric Wichems
Executive officer and director
DP
Daniel Pelak
Director
Ittai Harel
Director
RC
Rebecca Colbert
Executive officer